Universal-Beteiligungs- und Servicegesellschaft’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
SIMG
EA
N
EMFAT
PAM
Universal-Beteiligungs- und Servicegesellschaft's TVTX Position: Q2 2026 in Review
Universal-Beteiligungs- und Servicegesellschaft reduced its Travere Therapeutics (TVTX) stake by 0.83% in Q2 2026, selling an estimated $90.5K and leaving 244,606 shares worth $13.9M. The position accounts for 0.02% of the portfolio, ranked #533.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in TVTX in Q4 2024 and has held it in 7 quarters since. 169 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Universal-Beteiligungs- und Servicegesellschaft held 244,606 shares of Travere Therapeutics worth $13.9M as of Q2 2026.
- Universal-Beteiligungs- und Servicegesellschaft sold 2,042 Travere Therapeutics shares in Q2 2026, an estimated $90.5K.
- Travere Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #533 holding.
- Universal-Beteiligungs- und Servicegesellschaft first reported a position in Travere Therapeutics in Q4 2024 and has held it in 7 quarters since.
- 169 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.